levodopa has been researched along with cgp 35348 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernardi, G; Federici, M; Mercuri, NB | 1 |
| Beckstead, MJ; Grandy, DK; Wickman, K; Williams, JT | 1 |
| Bunzow, JR; Gantz, SC; Williams, JT | 1 |
3 other study(ies) available for levodopa and cgp 35348
| Article | Year |
|---|---|
Inhibition of catechol-O-methyltransferase (COMT) in the brain does not affect the action of dopamine and levodopa: an in vitro electrophysiological evidence from rat mesencephalic dopamine neurons.
Topics: Animals; Benzophenones; Catechol O-Methyltransferase Inhibitors; Cells, Cultured; Dopamine; Dopamine Antagonists; Electrophysiology; Enzyme Inhibitors; GABA Antagonists; Glycine Agents; Levodopa; Male; Neurons; Nitrophenols; Organophosphorus Compounds; Parkinson Disease; Picrotoxin; Rats; Rats, Wistar; Strychnine; Substantia Nigra; Sulpiride; Synaptic Transmission; Tolcapone; Ventral Tegmental Area | 1999 |
Vesicular dopamine release elicits an inhibitory postsynaptic current in midbrain dopamine neurons.
Topics: Action Potentials; Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Calcium; Calcium Channel Blockers; Cocaine; Dopamine; Dopamine Agents; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Electric Stimulation; Female; G Protein-Coupled Inwardly-Rectifying Potassium Channels; GABA Antagonists; In Vitro Techniques; Iontophoresis; Levodopa; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Mice, Knockout; Neural Inhibition; Neurons; Organophosphorus Compounds; Potassium Channels; Potassium Channels, Inwardly Rectifying; Receptors, Dopamine D2; Receptors, Dopamine D3; Reserpine; Sodium Channel Blockers; Sulpiride; Tetrodotoxin | 2004 |
Spontaneous inhibitory synaptic currents mediated by a G protein-coupled receptor.
Topics: Analysis of Variance; Animals; Chelating Agents; Colforsin; Dopamine; Dopamine Agents; Egtazic Acid; Female; GABA Antagonists; Humans; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Levodopa; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Transgenic; Neurons; Organophosphorus Compounds; Patch-Clamp Techniques; Receptors, Dopamine D2; Receptors, G-Protein-Coupled; Serotonin Agents; Tyrosine 3-Monooxygenase | 2013 |